CD274 and neoplasm: Given the difficulty of obtaining tumor tissue from metastases from CRPC patients, exploring minimally invasive approaches for interrogating potential circulating biomarkers (PD-L1/2+ DCs and PD-1+ T cells) and how they correlate to tumor PD-L1 expression is especially attractive.